Title : Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects.

Pub. Date : 2015 Apr 1

PMID : 25753330






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects. Curcumin epidermal growth factor receptor Homo sapiens
2 Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects. Curcumin epidermal growth factor receptor Homo sapiens
3 Curcumin (1) down-regulates the expression as well as phosphorylation of epidermal growth factor receptor (EGFR) in lung adenocarcinoma cells expressing gefitinib-resistant EGFR. Curcumin epidermal growth factor receptor Homo sapiens
4 Curcumin (1) down-regulates the expression as well as phosphorylation of epidermal growth factor receptor (EGFR) in lung adenocarcinoma cells expressing gefitinib-resistant EGFR. Curcumin epidermal growth factor receptor Homo sapiens
5 Curcumin (1) down-regulates the expression as well as phosphorylation of epidermal growth factor receptor (EGFR) in lung adenocarcinoma cells expressing gefitinib-resistant EGFR. Curcumin epidermal growth factor receptor Homo sapiens
6 Among all evaluated curcumin derivatives, compound 2 showed the best inhibitory effects on both wild-type and mutant EGFR by efficiently inducing gefitinib-insensitive EGFR degradation. Curcumin epidermal growth factor receptor Homo sapiens